Pertussis Vaccine Global Market Report 2025

Description

The pertussis vaccine is a vaccination designed to provide protection against whooping cough (pertussis), a highly contagious respiratory disease caused by the bacterium Bordetella pertussis. Its purpose is to stimulate the immune system to generate protective antibodies against the pertussis bacterium, thus reducing the risk of infection and the associated symptoms.

The main products related to the pertussis vaccine include the DTaP (diphtheria, tetanus, and acellular pertussis) vaccine and the Tdap (tetanus, diphtheria, and pertussis) vaccine. The DTaP vaccine, which is also known as the DTP vaccine, is a combination vaccine intended to safeguard against three serious bacterial infections such as diphtheria, tetanus, and pertussis (whooping cough). These vaccines are available in both whole-cell and acellular formulations and are administered to individuals of various age groups, including children, adults, and infants. They are typically administered by healthcare professionals at vaccination centers, hospitals, and clinics.

The pertussis vaccine market research report is one of a series of new reports from The Business Research Company that provides pertussis vaccine market statistics, including pertussis vaccine industry global market size, regional shares, competitors with a pertussis vaccine market share, detailed pertussis vaccine market segments, market trends and opportunities and any further data you may need to thrive in the pertussis vaccine industry. This pertussis vaccine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The pertussis vaccine market size has grown steadily in recent years. It will grow from $5.5 billion in 2024 to $5.72 billion in 2025 at a compound annual growth rate (CAGR) of 4.1%. The growth in the historic period can be attributed to disease prevalence, immunization programs, pediatric vaccination, regulatory approvals.

The pertussis vaccine market size is expected to see steady growth in the next few years. It will grow to $6.62 billion in 2029 at a compound annual growth rate (CAGR) of 3.7%. The growth in the forecast period can be attributed to booster vaccination, maternal immunization, immunization for healthcare workers, global health initiatives. Major trends in the forecast period include personalized immunization schedules, combination vaccines, vaccine equity initiatives, digital health for immunization.

Increasing childbirth rates are fueling the growth of the pertussis vaccine market. Childbirth refers to the process of delivering a baby, marking the end of pregnancy when the fetus, which has developed in the mother's uterus, begins life outside the womb. The pertussis vaccine is primarily administered to children to protect them from whooping cough and other serious, potentially life-threatening diseases. For example, in January 2023, a report from the Centers for Disease Control and Prevention, a US-based national public health agency, revealed a 1% increase in registered births in the United States, with a total of 3,664,292 births, compared to the previous year. As a result, the rising childbirth rates are driving the growth of the pertussis vaccine market.

The continuous growth of the geriatric population is anticipated to drive the expansion of the pertussis vaccine market. The geriatric population encompasses individuals in their later stages of life, typically aged 65 and older. The expanding number of older adults is a key contributor to the pertussis vaccine market. As more people enjoy longer lifespans, there is a heightened demand for pertussis vaccines to protect older individuals from this serious disease. For instance, in October 2022, the Switzerland-based World Health Organization projected that the global population of individuals aged 60 years and above is set to double by 2050, reaching 2.1 billion. Simultaneously, the number of individuals aged 80 years or older is expected to triple from 2020 to 2050, totaling 426 million. Consequently, the growing geriatric population is fostering the growth of the pertussis vaccine market.

Major enterprises engaged in the pertussis vaccine market are actively advancing innovative vaccines and securing regulatory approvals to maintain their market position. For instance, in October 2022, GSK plc., a UK-based pharmaceutical and biotechnology company, announced the U.S. Food and Drug Administration (FDA) approval of BOOSTRIX. BOOSTRIX is a tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine adsorbed (Tdap) vaccine. It is administered during pregnancy to prevent pertussis (whooping cough) in newborn infants and is administered as a single upper arm muscle injection. Boostrix is recognized for its safety and effectiveness in pregnant women and their infants, effectively preventing pertussis, including severe cases of the disease.

In May 2022, GSK plc., a UK-based pharmaceutical and biotechnology company, completed the acquisition of Affinivax Inc. for a sum of $2.1 billion. This strategic acquisition is a step taken by GSK to broaden its vaccine portfolio, enhance its outreach to patients, bolster its vaccine research and development pipeline, gain access to a potentially groundbreaking technology, and expand its scientific presence in the Boston region. Affinivax Inc. is a U.S.-based biotechnology enterprise specialized in the development of pertussis vaccines.

Major companies operating in the pertussis vaccine market are Pfizer Inc., Johnson And Johnson Pvt Ltd., Merck And Co. Inc., Novartis AG, GlaxoSmithKline PLC, AstraZeneca PLC, BioNTech SE, Moderna Inc., Sinovac Biotech Ltd., CSL Limited, Astellas Pharma US Inc., Sanofi Pasteur SA, Mitsubishi Tanabe Pharma America Inc., PT Kalbe Farma Tbk, CSL Seqirus, Walvax Biotechnology Co.Ltd., Biological E. Limited, Serum Institute of India, Bavarian Nordic AS, PT Bio Farma, Bharat Biotech International Limited, Takeda Pharmaceutical Company, Panacea Biotec Limited, Beijing Minhai Biotechnology Co. Ltd., Protein Sciences Corporation, Wuhan Institute of Biological Products, Changchun Changsheng Life Sciences, Changsheng Bio-Technology Co. Ltd., Gennova Biopharmaceuticals Ltd., Chiron Corporation.

North America was the largest region in the pertussis vaccine market in 2024. The regions covered in pertussis vaccine report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the pertussis vaccine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pertussis vaccine market consists of sales of adacel, daptacel, infanrix, kinrix, pediarix, pentacel and quadracel. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pertussis Vaccine Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pertussis vaccine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pertussis vaccine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pertussis vaccine market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Product Type: DTaP (Diphtheria, Tetanus and Acellular Pertussis) Vaccine; Tdap (Tetanus, Diphtheria and Pertussis) Vaccine
2) By Vaccine Type: Whole-Cell Vaccine; Acellular Vaccine
3) By Application: Children; Adults; Infants
4) By End-User: Vaccination Centers; Hospitals; Clinics
Subsegments:
1) By DTaP (Diphtheria, Tetanus, And Acellular Pertussis) Vaccine: Pediatric DTaP Vaccine; Combination Vaccines With DTaP
2) By Tdap (Tetanus, Diphtheria, And Pertussis) Vaccine: Adolescent Tdap Vaccine; Adult Tdap Vaccine
Companies Mentioned: Pfizer Inc.; Johnson And Johnson Pvt Ltd.; Merck And Co. Inc.; Novartis AG; GlaxoSmithKline plc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r28729

1. Executive Summary

2. Pertussis Vaccine Market Characteristics

3. Pertussis Vaccine Market Trends And Strategies

4. Pertussis Vaccine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Pertussis Vaccine Growth Analysis And Strategic Analysis Framework

5.1. Global Pertussis Vaccine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Pertussis Vaccine Market Growth Rate Analysis
5.4. Global Pertussis Vaccine Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Pertussis Vaccine Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Pertussis Vaccine Total Addressable Market (TAM)

6. Pertussis Vaccine Market Segmentation

6.1. Global Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
DTaP (Diphtheria, Tetanus and Acellular Pertussis) Vaccine
Tdap (Tetanus, Diphtheria and Pertussis) Vaccine
6.2. Global Pertussis Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Whole-Cell Vaccine
Acellular Vaccine
6.3. Global Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Children
Adults
Infants
6.4. Global Pertussis Vaccine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Vaccination Centers
Hospitals
Clinics
6.5. Global Pertussis Vaccine Market, Sub-Segmentation Of DTaP (Diphtheria, Tetanus and Acellular Pertussis) Vaccine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pediatric DTaP Vaccine
Combination Vaccines With DTaP
6.6. Global Pertussis Vaccine Market, Sub-Segmentation Of Tdap (Tetanus, Diphtheria and Pertussis) Vaccine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Adolescent Tdap Vaccine
Adult Tdap Vaccine

7. Pertussis Vaccine Market Regional And Country Analysis

7.1. Global Pertussis Vaccine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Pertussis Vaccine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pertussis Vaccine Market

8.1. Asia-Pacific Pertussis Vaccine Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Pertussis Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pertussis Vaccine Market

9.1. China Pertussis Vaccine Market Overview
9.2. China Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Pertussis Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pertussis Vaccine Market

10.1. India Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Pertussis Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pertussis Vaccine Market

11.1. Japan Pertussis Vaccine Market Overview
11.2. Japan Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Pertussis Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pertussis Vaccine Market

12.1. Australia Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Pertussis Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pertussis Vaccine Market

13.1. Indonesia Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Pertussis Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pertussis Vaccine Market

14.1. South Korea Pertussis Vaccine Market Overview
14.2. South Korea Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Pertussis Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pertussis Vaccine Market

15.1. Western Europe Pertussis Vaccine Market Overview
15.2. Western Europe Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Pertussis Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pertussis Vaccine Market

16.1. UK Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Pertussis Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pertussis Vaccine Market

17.1. Germany Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Pertussis Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pertussis Vaccine Market

18.1. France Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Pertussis Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pertussis Vaccine Market

19.1. Italy Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Pertussis Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pertussis Vaccine Market

20.1. Spain Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Pertussis Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pertussis Vaccine Market

21.1. Eastern Europe Pertussis Vaccine Market Overview
21.2. Eastern Europe Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Pertussis Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pertussis Vaccine Market

22.1. Russia Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Pertussis Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pertussis Vaccine Market

23.1. North America Pertussis Vaccine Market Overview
23.2. North America Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Pertussis Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pertussis Vaccine Market

24.1. USA Pertussis Vaccine Market Overview
24.2. USA Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Pertussis Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pertussis Vaccine Market

25.1. Canada Pertussis Vaccine Market Overview
25.2. Canada Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Pertussis Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pertussis Vaccine Market

26.1. South America Pertussis Vaccine Market Overview
26.2. South America Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Pertussis Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pertussis Vaccine Market

27.1. Brazil Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Pertussis Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pertussis Vaccine Market

28.1. Middle East Pertussis Vaccine Market Overview
28.2. Middle East Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Pertussis Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pertussis Vaccine Market

29.1. Africa Pertussis Vaccine Market Overview
29.2. Africa Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Pertussis Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pertussis Vaccine Market Competitive Landscape And Company Profiles

30.1. Pertussis Vaccine Market Competitive Landscape
30.2. Pertussis Vaccine Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Johnson And Johnson Pvt Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Merck And Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis

31. Pertussis Vaccine Market Other Major And Innovative Companies

31.1. AstraZeneca plc
31.2. BioNTech SE
31.3. Moderna Inc.
31.4. Sinovac Biotech Ltd.
31.5. CSL Limited
31.6. Astellas Pharma US Inc.
31.7. Sanofi Pasteur SA
31.8. Mitsubishi Tanabe Pharma America Inc.
31.9. PT Kalbe Farma Tbk
31.10. CSL Seqirus
31.11. Walvax Biotechnology Co.Ltd.
31.12. Biological E. Limited
31.13. Serum Institute of India
31.14. Bavarian Nordic AS
31.15. PT Bio Farma

32. Global Pertussis Vaccine Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pertussis Vaccine Market

34. Recent Developments In The Pertussis Vaccine Market

35. Pertussis Vaccine Market High Potential Countries, Segments and Strategies

35.1 Pertussis Vaccine Market In 2029 - Countries Offering Most New Opportunities
35.2 Pertussis Vaccine Market In 2029 - Segments Offering Most New Opportunities
35.3 Pertussis Vaccine Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer